Redcare Pharmacy NV (BIT:1RDC)
Italy · Delayed Price · Currency is EUR 105.80
0.00 (0.00%)
Last updated: Aug 8, 2025
Redcare Pharmacy NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 2,676 | 2,371 | 1,799 | 1,204 | 1,060 | 968.06 | Upgrade | |
Revenue Growth (YoY) | 25.78% | 31.79% | 49.35% | 13.58% | 9.53% | 38.09% | Upgrade |
Cost of Revenue | 2,056 | 1,825 | 1,358 | 872.57 | 793.53 | 748.53 | Upgrade |
Gross Profit | 619.8 | 545.78 | 440.38 | 331.79 | 266.8 | 219.53 | Upgrade |
Selling, General & Admin | 655.26 | 581.07 | 444.49 | 379.17 | 299.21 | 214.04 | Upgrade |
Other Operating Expenses | -0.51 | -0.35 | -0.32 | -0.15 | -0.16 | -0.07 | Upgrade |
Operating Expenses | 654.75 | 580.73 | 444.18 | 379.02 | 299.05 | 213.97 | Upgrade |
Operating Income | -34.95 | -34.95 | -3.79 | -47.23 | -32.25 | 5.56 | Upgrade |
Interest Expense | -15.31 | -7.78 | -8 | -8.5 | -8.57 | -10.76 | Upgrade |
Interest & Investment Income | 20.08 | 6.4 | 4.61 | - | - | - | Upgrade |
Earnings From Equity Investments | 0.74 | 0.42 | 0.23 | 0.34 | -0.43 | 0.05 | Upgrade |
Currency Exchange Gain (Loss) | 0.52 | 0.52 | 0.28 | 1.76 | 1.49 | -0.23 | Upgrade |
Other Non Operating Income (Expenses) | -8.37 | -8.37 | -7.02 | -6.97 | -4.53 | -3.72 | Upgrade |
EBT Excluding Unusual Items | -37.3 | -43.76 | -13.7 | -60.6 | -44.28 | -9.11 | Upgrade |
Merger & Restructuring Charges | - | - | - | -0.32 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | -1.58 | -0.16 | -0.4 | Upgrade |
Other Unusual Items | -5.09 | -4.08 | -0.65 | -21.62 | -33.45 | -6.42 | Upgrade |
Pretax Income | -42.39 | -47.83 | -14.35 | -84.12 | -77.88 | -15.93 | Upgrade |
Income Tax Expense | -6.25 | -1.48 | -2.74 | -6.47 | -3.7 | 0.84 | Upgrade |
Earnings From Continuing Operations | -36.14 | -46.36 | -11.61 | -77.65 | -74.19 | -16.77 | Upgrade |
Minority Interest in Earnings | 1.29 | 0.89 | -0.44 | - | - | - | Upgrade |
Net Income | -34.86 | -45.46 | -12.04 | -77.65 | -74.19 | -16.77 | Upgrade |
Net Income to Common | -34.86 | -45.46 | -12.04 | -77.65 | -74.19 | -16.77 | Upgrade |
Shares Outstanding (Basic) | 20 | 20 | 19 | 18 | 18 | 14 | Upgrade |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 18 | 18 | 14 | Upgrade |
Shares Change (YoY) | 0.98% | 4.24% | 6.97% | 0.57% | 24.37% | 10.07% | Upgrade |
EPS (Basic) | -1.73 | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | Upgrade |
EPS (Diluted) | -1.74 | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | Upgrade |
Free Cash Flow | 0.87 | 13.38 | 55.02 | -42.68 | -2.18 | -20.43 | Upgrade |
Free Cash Flow Per Share | 0.04 | 0.67 | 2.86 | -2.37 | -0.12 | -1.42 | Upgrade |
Gross Margin | 23.16% | 23.02% | 24.48% | 27.55% | 25.16% | 22.68% | Upgrade |
Operating Margin | -1.31% | -1.47% | -0.21% | -3.92% | -3.04% | 0.57% | Upgrade |
Profit Margin | -1.30% | -1.92% | -0.67% | -6.45% | -7.00% | -1.73% | Upgrade |
Free Cash Flow Margin | 0.03% | 0.56% | 3.06% | -3.54% | -0.21% | -2.11% | Upgrade |
EBITDA | -12.15 | -12.83 | 14.47 | -34 | -21.6 | 12.8 | Upgrade |
EBITDA Margin | -0.45% | -0.54% | 0.80% | -2.82% | -2.04% | 1.32% | Upgrade |
D&A For EBITDA | 22.8 | 22.12 | 18.27 | 13.23 | 10.65 | 7.24 | Upgrade |
EBIT | -34.95 | -34.95 | -3.79 | -47.23 | -32.25 | 5.56 | Upgrade |
EBIT Margin | -1.31% | -1.47% | -0.21% | -3.92% | -3.04% | 0.57% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.